findmyKOL

Leslie Crofford, MD

Enriched profile

Director, Vanderbilt Center for Bone Biology; Professor of Medicine; Professor of Pathology, Microbiology & Immunology, Division of Rheumatology & Immunology, Vanderbilt University Medical Center · Vanderbilt University Medical Center

ORCIDNPI
Region🇺🇸 Nashville, TN · Southeast · United StatesSpecialtyRheumatologyFocusFibromyalgia and Chronic Fatigue Syndrome Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2024–2025NIH funding2013–2024

Leslie Crofford is Director, Vanderbilt Center for Bone Biology; Professor of Medicine; Professor of Pathology, Microbiology & Immunology, Division of Rheumatology & Immunology, Vanderbilt University Medical Center at Vanderbilt University Medical Center. OpenAlex indexes 434 publications with 24,927 citations (h-index 78); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 1 Sept 2026

Leslie Crofford, MD, is Director, Vanderbilt Center for Bone Biology at Vanderbilt University Medical Center. The public record shows 434 publications with 24,927 citations (h-index 78), centered on Fibromyalgia and Chronic Fatigue Syndrome Research, Musculoskeletal pain and rehabilitation, Inflammatory mediators and NSAID effects. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 2 companies, 3 NIH-funded awards (2013–2024).

  • Most recent indexed publication: 2026 · International urogynecology journal
  • Top research focus: Fibromyalgia and Chronic Fatigue Syndrome Research
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ST Elevation Myocardial Infarction4 trialsFibromyalgia3 trialsMyalgia3 trialsScleroderma, Systemic2 trialsLupus (SLE)2 trialsErythema2 trialsAutoimmune Diseases1 trialLupus Vasculitis, Central Nervous System1 trialRheumatoid Arthritis

Research focus

OpenAlex concept fingerprint
Fibromyalgia and Chronic Fatigue Syndrome ResearchMusculoskeletal pain and rehabilitationInflammatory mediators and NSAID effectsSystemic Sclerosis and Related DiseasesRheumatoid Arthritis Research and Therapies

Drugs & molecules

across trials, industry payments and publications
Rystiggogeneric · RozanolixizumabClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Genentech, Inc.Clinical trialsIndustry payments2Kathleen SlukaClinical trials2Industry paymentsNational Institute of Allergy and Infectious Diseases (NIAID)Clinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
434publications

Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.

24,927citations

Total citations across indexed works.

78h-index

Hirsch index (OpenAlex). i10-index 251.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
2companies · 2024–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2013–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 1 Sept 2026

2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    50%
    TNF inhibitor50%
    Enbrel Sureclick100%
    Part D<11 patients
  • Respiratory

    50%
    Opioid Agonist50%
    Hydrocodone-Acetaminophen100%
    Part D<11 patients
Where care is delivered (Part B), 20220% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 1 Sept 2026

3 NIH research awards on record, funded 20132024 per NIH RePORTER. The latest:

Publications

Updated 1 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 1 Sept 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/leslie-crofford-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • ResearchGate

    researchgate.net/scientific-contributions/Leslie-J-Crofford-39529898

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.